(a) At the same time as medical cannabis is dispensed or administered, the bureau shall gather information and statistics from available sources, to include The Centennial Institute, The Rocky Mountain High Intensity Drug Trafficking Area, and others that may be relevant for presentation to the legislature.

(b) While the study is ongoing, medical cannabis may be dispensed or administered. At the conclusion of the study the Legislature will have the opportunity to review the study outlined in section two of this article and make any necessary recommendations or changes to the medical cannabis program.

(a) Information provided to the Legislature shall include, at a minimum, relative information from states with experience with medical cannabis regulation, administration, dispensing, effectiveness, and social and economic impact on the state. Specific information shall include:

(1) The number of medical cannabis cardholders, patients, or both over a time period of at least five years;

(2) By percentage, the age ranges of cardholders, patients, or both;

(3) The medical conditions for which medical cannabis was dispensed and the percentage in each category;

(4) Statistics related to alcohol consumption prior to and post medical cannabis;

(5) Statistics related to illegal opioid and other drug use prior to and post medical cannabis;

(6) Statistics related to medical cannabis and tobacco use;

(7) Medical cannabis diversion statistics;

(8) Statistics relative to automobile accidents, injuries, driving under the influence, and monetary costs;

(9) The number of medical cannabis users who may have transitioned to recreational in cases where recreational use was later legalized;

(10) Information to determine the percentage of medical cannabis users who develop an addiction to cannabis;

(11) Cost associated with cannabis use disorders;

(12) Calls to poison control centers for cannabis, along with what forms of cannabis are involved in the call, and the cost associated;

(13) Hospitalizations related to cannabis and the associated cost;

(14) Cannabis use and correlation to low-weight babies born to mothers who use cannabis and the effects on the babies and related costs;

(15) Arrests related to cannabis and associated cost;

(16) Effect of cannabis use on education attainment;

(17) Effect of cannabis use on employment, workforce, and productivity, and the costs associated with those categories; and

(18) Any other information the bureau wishes to compile for additional research into cannabis use and the effects on persons, society, and the economy.

(b) The bureau shall aggregate data from West Virginia dispensaries and include West Virginia patient statistics to compare the progress of this state to the information outlined in subsection (a) of this section for review by the Legislature.”